DK1807518T3 - Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf - Google Patents
Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse herafInfo
- Publication number
- DK1807518T3 DK1807518T3 DK05764041.9T DK05764041T DK1807518T3 DK 1807518 T3 DK1807518 T3 DK 1807518T3 DK 05764041 T DK05764041 T DK 05764041T DK 1807518 T3 DK1807518 T3 DK 1807518T3
- Authority
- DK
- Denmark
- Prior art keywords
- afp
- fetoprotein
- preparation
- agents
- methods
- Prior art date
Links
- 102000013529 alpha-Fetoproteins Human genes 0.000 title abstract 5
- 108010026331 alpha-Fetoproteins Proteins 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 101000848653 Homo sapiens Tripartite motif-containing protein 26 Proteins 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 102000046101 human AFP Human genes 0.000 abstract 2
- 101000827785 Homo sapiens Alpha-fetoprotein Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002906 microbiologic effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Gynecology & Obstetrics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Reproductive Health (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA200400907A EA011606B1 (ru) | 2004-07-14 | 2004-07-14 | Способы получения и применения рекомбинантного альфа-фетопротеина |
| PCT/RU2005/000369 WO2006009492A1 (en) | 2004-07-14 | 2005-07-07 | Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1807518T3 true DK1807518T3 (da) | 2012-07-30 |
Family
ID=35785507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05764041.9T DK1807518T3 (da) | 2004-07-14 | 2005-07-07 | Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7910327B2 (da) |
| EP (1) | EP1807518B1 (da) |
| JP (1) | JP2008506384A (da) |
| CN (1) | CN1993469B (da) |
| AT (1) | ATE555205T1 (da) |
| DK (1) | DK1807518T3 (da) |
| EA (1) | EA011606B1 (da) |
| ES (1) | ES2384863T3 (da) |
| PT (1) | PT1807518E (da) |
| WO (1) | WO2006009492A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070111936A1 (en) * | 2005-11-15 | 2007-05-17 | Vladimir Pak | Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer |
| CA2670341C (en) * | 2006-11-28 | 2015-05-26 | University Of Central Florida Research Foundation, Inc. | Vigor enhancement via administration of pyrimidine derivatives |
| JP5555922B2 (ja) | 2008-09-16 | 2014-07-23 | ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド | 脱毛を治療する、又は、脱毛の発症を遅らせるための組成物 |
| KR101259564B1 (ko) * | 2009-02-11 | 2013-04-30 | 건국대학교 산학협력단 | 항산화 활성을 가지는 피부 보호용 조성물 |
| CN102993292A (zh) * | 2012-12-14 | 2013-03-27 | 上海柯莱逊生物技术有限公司 | 一种afp重组蛋白和体外重组表达的方法 |
| FI20130341L (fi) | 2013-11-19 | 2015-05-20 | Safemed Ltd Oy | Huonosti vesiliukoisten lääkeaineiden kuljetus metalli-ioneilla tasapainotetun alfafetoproteiinin mukana |
| RU2617943C2 (ru) * | 2015-07-17 | 2017-04-28 | Общество с ограниченной ответственностью "Научно-производственное предприятие "Ферментные технологии" (ООО "НПП "Ферментные технологии") | Рекомбинантный фрагмент ДНК, кодирующий альфа-фетопротеин (АФП) человека, содержащий "медленные" кодоны, кодирующие лейцин, экспрессионная плазмида, содержащая указанный фрагмент, клетка Saccharomyces cerevisiae, трансформированная указанной плазмидой, и способ получения рекомбинантного АФП человека |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2559592A (en) * | 1947-02-21 | 1951-07-10 | Leslie M Button | Vapor or fog nozzle |
| GB718847A (en) * | 1952-09-25 | 1954-11-24 | Allman Patents Ltd | Improvements in spraying apparatus |
| GB798645A (en) * | 1955-08-05 | 1958-07-23 | Dorman Sprayer Company Ltd | Improvements in or relating to spraying nozzles |
| GB1007304A (en) * | 1963-09-16 | 1965-10-13 | Ici Australia Ltd | Nozzle |
| DE2554723C3 (de) * | 1975-12-05 | 1978-11-23 | Hans Grohe Gmbh & Co Kg, 7622 Schiltach | Schwallbrause |
| DE2654228C3 (de) * | 1976-11-30 | 1979-05-23 | Robert Bosch Gmbh, 7000 Stuttgart | Waschanlage für Abdeckscheiben von Kraftfahrzeugleuchten |
| GB2121318B (en) * | 1982-06-01 | 1985-10-02 | Smiths Industries Plc | Improvements relating to spray nozzles |
| US5139936A (en) | 1983-02-28 | 1992-08-18 | Collaborative Research, Inc. | Use of the GAL1 yeast promoter |
| FR2624149B1 (fr) * | 1987-12-04 | 1991-04-26 | Planchon Alain | Guide-jet plat divergent pour installation sanitaire |
| US5206153A (en) | 1990-06-27 | 1993-04-27 | Snow Brand Milk Products Co., Ltd. | Method of producing human α-fetoprotein and product produced thereby |
| US5965528A (en) | 1991-09-27 | 1999-10-12 | Mcgill University | Recombinant human alph-fetoprotein as an immunosuppressive agent |
| US6288034B1 (en) * | 1995-01-24 | 2001-09-11 | Martinex R & D Inc. | Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| US6331611B1 (en) * | 1991-09-27 | 2001-12-18 | Mcgill University | Expression and purification of cloned human alpha-fetoprotein |
| CA2120131A1 (en) * | 1991-09-27 | 1994-05-11 | Robert A. Murgita | Expression and purification of cloned human alpha-fetoprotein |
| WO1994008012A1 (en) * | 1992-10-02 | 1994-04-14 | Research Corporation Technologies, Inc. | Methods for increasing secretion of overexpressed proteins |
| US7101837B1 (en) | 1995-01-24 | 2006-09-05 | Martinex R & D Inc. | Recombinant human alpha-fetoprotein as a cell proliferative agent |
| US6534479B1 (en) | 1995-01-24 | 2003-03-18 | Martinex R & D Inc. | Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers |
| RU2142784C1 (ru) | 1997-04-03 | 1999-12-20 | Закрытое акционерное общество Научно-производственный центр "Сибирская природная косметика" | Косметическое средство для ухода за кожей "гармония" |
| RU2142785C1 (ru) * | 1997-04-03 | 1999-12-20 | Закрытое акционерное общество Научно-производственный центр "Сибирская природная косметика" | Косметическое средство для ухода за кожей "гармония-n" или "гармония-r" |
| KR20010034305A (ko) | 1998-01-23 | 2001-04-25 | 한센 핀 베네드 | 효모에서 원하는 폴리펩티드를 만드는 방법 |
| WO2000053759A1 (en) * | 1999-03-09 | 2000-09-14 | Atlantic Biopharmaceuticals, Inc. | Expression of human alpha-fetoprotein in mammalian cells |
| JP4447726B2 (ja) * | 2000-03-27 | 2010-04-07 | 株式会社共立合金製作所 | 流体噴射ノズル |
-
2004
- 2004-07-14 EA EA200400907A patent/EA011606B1/ru not_active IP Right Cessation
-
2005
- 2005-07-07 WO PCT/RU2005/000369 patent/WO2006009492A1/en active Application Filing
- 2005-07-07 ES ES05764041T patent/ES2384863T3/es active Active
- 2005-07-07 DK DK05764041.9T patent/DK1807518T3/da active
- 2005-07-07 EP EP05764041A patent/EP1807518B1/en not_active Not-in-force
- 2005-07-07 JP JP2007521429A patent/JP2008506384A/ja active Pending
- 2005-07-07 AT AT05764041T patent/ATE555205T1/de active
- 2005-07-07 US US11/632,409 patent/US7910327B2/en not_active Expired - Fee Related
- 2005-07-07 CN CN2005800261655A patent/CN1993469B/zh not_active Expired - Fee Related
- 2005-07-07 PT PT05764041T patent/PT1807518E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1807518A4 (en) | 2008-04-16 |
| ATE555205T1 (de) | 2012-05-15 |
| EA011606B1 (ru) | 2009-04-28 |
| US7910327B2 (en) | 2011-03-22 |
| WO2006009492A8 (en) | 2006-04-27 |
| EP1807518A1 (en) | 2007-07-18 |
| CN1993469A (zh) | 2007-07-04 |
| WO2006009492A1 (en) | 2006-01-26 |
| ES2384863T3 (es) | 2012-07-13 |
| EA200400907A1 (ru) | 2006-02-24 |
| JP2008506384A (ja) | 2008-03-06 |
| US20090233849A1 (en) | 2009-09-17 |
| CN1993469B (zh) | 2011-07-20 |
| EP1807518B1 (en) | 2012-04-25 |
| PT1807518E (pt) | 2012-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1807518T3 (da) | Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf | |
| MX2020006065A (es) | Metodos y productos para la produccion y administracion de acido nucleico. | |
| WO2007084342A3 (en) | Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells | |
| WO2013006953A8 (en) | Genes and proteins for alkanoyl-coa synthesis | |
| ATE550356T1 (de) | Chimäre t-zellen-rezeptoren sowie entsprechende materialien und verwendungsverfahren | |
| WO2013158309A3 (en) | Non-disruptive gene targeting | |
| UY30826A1 (es) | Nuevo gen bacillus thuringiensis con actividad contra lepidópteros | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| WO2008093165A3 (en) | The use of pgil ohgosaccharyltransferase for o-glycosylating proteins | |
| DK1904636T3 (da) | Forbedringer inden for eller i sammenhæng med proteinfremstilling | |
| NO20055209L (no) | Peptabody for cancerbehandling | |
| DE60332993D1 (de) | Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung | |
| WO2013096958A8 (en) | Compositions and methods for the delivery of biologically active rnas | |
| MX2010006211A (es) | Proteínas elastasa recombinantes y métodos de fabricación y uso de las mismas. | |
| AR070143A1 (es) | Gen de bacillus thuringiensis (bt) con actividad contra coleopteros | |
| ATE473235T1 (de) | Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung | |
| WO2012173344A3 (ko) | Ｃｓｐ－ｂ ５'-ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법 | |
| MX2021011039A (es) | Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con fviii. | |
| DE602005021159D1 (de) | Bakteriophagen- und prophagen-proteine in der krebsgentherapie | |
| MX2022011806A (es) | Vectores de adn no virales y usos de estos para expresar agentes terapéuticos contra gaucher. | |
| GT200600210A (es) | Terapia genica de interferon-beta usdando un sistema mejorado de expresion regulada | |
| Nicola Candia et al. | Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer | |
| WO2007107380A3 (en) | Use of pol iii promoters for controlled expression of therapeutic proteins | |
| WO2015009596A3 (en) | Methods and oral formulations for enzyme replacement therapy of human lysosomal and metabolic diseases | |
| AR070142A1 (es) | Gen de bacillus thuringiensis con actividad contra coleopteros |